Annual report pursuant to Section 13 and 15(d)

Stock Options (Details Narrative)

v3.10.0.1
Stock Options (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Number of stock options granted 1,400,418 880,667
Exercise price of common stock granted $ 6.75 $ 2.55
Number of common stock exercised 32,508
Number of common stock exercised, value $ 34,000  
Employees and Consultants [Member]    
Number of stock options granted 1,400,418 880,667
Exercise price of common stock granted $ 6.75 $ 2.55
Expiration period 5 years 5 years
Stock option vesting period 4 years 3 years
Fair value of stock options grants $ 9,712,000 $ 1,781,000
Expense recognized relating to stock options 1,870,000  
Unrecognized stock based compensation expense $ 6,591,000 $ 418,000
Stock option, description Expected to be recognized as part of operating expense through December 2021.